Typically, the designation "V2R" would be associated with a subclass of receptors within the vasopressin receptor family, which are G protein-coupled receptors responsive to the vasopressin hormone. The "13" could imply a specific subtype or a particular code used in a research context to denote a specific receptor or research model. Assuming V2R13 refers to a specialized receptor, activators of this receptor would be compounds that selectively bind to and increase the activity of the V2R13 receptor. Such activators would likely facilitate the receptor's natural response to its ligand or could mimic the action of the ligand itself, promoting downstream signaling pathways. The molecular structures of V2R13 activators would be highly specific to the binding site and the conformation of the receptor, potentially encompassing a range of small molecules, peptides, or other specialized ligands engineered to interact precisely with this receptor subtype.
In a research setting where V2R13 refers to a specific receptor, the study of V2R13 activators would involve a detailed understanding of the receptor's structure and function. Scientists would employ techniques such as ligand-binding assays to screen for compounds that exhibit an affinity for the receptor and can promote its activation. This could involve the use of radiolabeled ligands or fluorescent probes to quantitatively measure receptor-ligand interactions. Following the identification of potential activators, further studies would be needed to characterize the binding kinetics and specificity of these compounds for V2R13. Techniques such as surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC) could yield insights into the strength and duration of the interaction between the activators and the receptor. Additionally, computational modeling and molecular dynamics simulations might be useful to predict how these activators engage with the receptor at the atomic level, providing a model of the receptor's activation mechanism. Research into the V2R13 receptor and its activators would contribute to a broader understanding of the signaling pathways in which this receptor is involved and could provide fundamental insights into the receptor's role within these pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(+)-cis,trans-Abscisic acid | 21293-29-8 | sc-202103 sc-202103A | 500 µg 1 mg | $105.00 $188.00 | ||
Can activate NF-κB signaling, potentially leading to the induction of TRIM gene expression as part of an inflammatory response. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Affects gene expression and cell differentiation, which could potentially influence TRIM protein expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
A polyphenol that can modulate several signaling pathways and might affect the expression of TRIM proteins. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Alters the degradation of transcription factors and may influence TRIM protein expression as part of its anti-inflammatory and immunomodulatory effects. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Modulates various signaling pathways and could potentially influence the expression of TRIM proteins. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
An HDAC inhibitor that can alter chromatin structure and potentially affect the expression of TRIM genes by modulating gene accessibility. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Affects sirtuin and AMPK signaling, potentially influencing TRIM protein expression associated with metabolism and stress response. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Influences Wnt/β-catenin signaling, which could have downstream effects on TRIM protein expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Can lead to the accumulation of regulatory proteins and potentially affect the expression of TRIM proteins. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methylation inhibitor that could lead to the reactivation of silenced genes, potentially affecting TRIM protein expression. | ||||||